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 The majority of the fosfomycin Etests shows growth of macrocolonies in the inhibition 
zone 
 Etest observations significantly underestimate the MIC of fosfomycin, compared to the 
reference standard Agar Dilution  
 The fosfomycin Etest has a low interobserver – interlaboratory agreement, with a higher 
agreement for E. coli compared to other Enterobacteriaceae 
 Ignoring all growth in the inhibition zone might improve Etest performance  
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Objectives: The increasing use of fosfomycin requires reliable susceptibility testing in clinical 
practice. The reference standard, Agar dilution (AD) is rarely used in routine settings. The 
fosfomycin Etest (BioMérieux) is frequently used, though the reading of MICs can be hampered 
by the interpretation of the growth of macrocolonies in the inhibition zone. We investigated the 
interobserver (IO), interlaboratory (IL), and interobserver-interlaboratory (IOIL) agreement of the 
fosfomycin Etest and evaluated the agreement to AD. 
Methods: Etests were performed for 57 ESBL-producing Enterobacteriaceae of four bacterial 
species (Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca and Enterobacter cloacae), 
in two laboratories. Photographs of fosfomycin Etests were interpreted by four observers 
following manufacturer’s instructions.  
Results: Essential Agreement (EA) and CA between Etest and AD was 57% and 89% (κ-value 
0.68), respectively, with an underestimation of Etest interpretations compared to AD of 0.26 
(95%CI: 0.03-0.48) 2-fold dilutions. Between Etest observations, IO-EA and -CA was reached in 
82% and 94%; IL-EA and -CA in 38% and 85%; and IOIL-EA and -CA in 40% and 85% of 
comparisons, respectively. Agreement of the Etest to AD and between Etests was better for 
E.coli than for other species. Ignoring all macrocolonies and haze from Etest interpretation, 
improved the agreement to AD (CA κ-value 0.80) and between Etests (CA κ-value from 0.68 to 
0.81).  
Conclusions: In this study on 57 ESBL-producing Enterobacteriaceae, IOIL agreement was 
low with an EA of 40% and a CA of 85%, affected most by IL agreement and to a lesser extent 




















Fosfomycin was discovered as antibiotic agent in 1969.1 Its use has gained renewed interest 
due to increasing resistance against other antibiotics, especially in Enterobacteriaceae.  
Fosfomycin susceptibility testing for Enterobacteriaceae is challenging in the routine setting. 
The reference standard, agar dilution, is complex and time consuming, making it unsuitable for 
routine clinical application.2 Performance of automated broth microdilution methods is not 
recommended by the Clinical and Laboratory Standards Institute (CLSI) or The European 
Committee on Antimicrobial Susceptibility Testing (EUCAST).3  
A potential alternative to determine the MIC of fosfomycin for Enterobacteriaceae is the Etest 
(BioMérieux, Durham, USA). Agreement to agar dilution varies and is described to be poor for 
Enterobacteriaceae other than Escherichia coli, attributed to difficulties in reading the Etest MIC 
due to growth of macrocolonies in the inhibition zone.4,5  The manufacturer instructs to ignore up 
to five macrocolonies when reading the MIC.  
 
To evaluate the Etest as an alternative fosfomycin testing method for the routine lab, we 
determined the interobserver (IO), interlaboratory (IL) and interobserver-interlaboratory (IOIL) 
essential and categorical agreement.  
 
 
Materials and methods: 
 
Isolates 
Isolates originated from a collection of well-defined and sequenced ESBL-producing 
Enterobacteriaceae from a multicentre study on transmission in Dutch hospitals.6 7 The 
selection of 57 isolates was based on the presence or absence of the FosA gene, the most 
frequent plasmid-borne fosfomycin resistance gene in Gram-negative bacteria, aiming at a 1:1 
ratio. 8 The selection comprised 16 Escherichia coli, 16 Enterobacter cloacae, 16 Klebsiella 














Agar dilution was performed on the selection of 57 isolates, according to CLSI guidelines.9 The 
bacteria were recovered from a fresh culture on a blood agar plate that was cultured overnight 
at 35-37°C. Next, a suspension of 0.5 McFarland of bacteria in 0.45% NaCl (108 CFU/mL) was 
made and diluted to 107 CFU/mL in 0.9% NaCl. Bacterial suspensions were pipetted per 12 into 
a 24- wells plate and replicated. Subsequently, 2 µL bacterial inoculum (±1x104 CFU/spot of 5-8 
mm) from each well was inoculated onto a Mueller-Hinton II agar plate, containing 25 mg/L 
glucose-6-phosphate and fosfomycin in concentrations from 0.25 mg/L to 128 mg/L. The agar 
plates were incubated for 16-20 hours at 35-37°C. The highest fosfomycin concentration, at 
which no visible bacterial growth on the agar plate was observed by the naked eye, was 
considered the MIC. Single colonies or a weak haze due to the bacterial inoculum were ignored.   
Etest susceptibility testing was performed according to the manufacturer’s instructions in two 
Dutch clinical microbiology laboratories. A suspension of 0.5 McFarland of overnight cultured 
bacteria in 0.85%NaCl was inoculated onto a Mueller-Hinton II agar (MHA: Oxoid in laboratory A 
and Becton Dickinson in laboratory B). In both laboratories a sterile swab was used, streaking 
the agar surface three times rotating the plate 60 degrees each time. Within 15 minutes after 
inoculation, Etest strips were applied onto the inoculated MHA. Plates were incubated for 16-20 
hours at 35-37 ºC. Photographs of the incubated agar plates were made to enable independent 
reading of inhibition zones (example in supplementary material). 
 
Etest interpretation 
Four clinical microbiology residents interpreted all photographs independently, resulting in 8 
separate Etest observations for 57 bacterial isolates. First, observers were instructed to register 
the number of macrocolonies present in the inhibition ellipse; second, to ignore all 
macrocolonies and haze to determine the MIC at 80% inhibition (MIC80%); and third, to include 
all macrocolonies to determine the MIC at 100% inhibition (MIC100%). According to 
manufacturer’s instructions, the MIC used for the main analysis (recommended MIC) was 




Essential agreement (EA) was defined as agreement of Etest MIC values within one MIC 
dilution step, and Categorical agreement (CA) as MIC values within the same EUCAST 
susceptibility category, i.e. susceptible (MIC ≤32 mg/L) or resistant (MIC >32 mg/L). 2 












Etest observations. Interobserver (IO) agreement was defined as agreement between individual 
observers within one laboratory; interlaboratory (IL) agreement as agreement between the 
observations of the same observer for Etests performed in the two laboratories and 
interobserver-interlaboratory (IOIL) agreement as agreement between combinations of different 
observers and different laboratories, best reflecting clinical practice. Disagreements were 
classified as very major errors (VME) if the Etest resulted in a susceptible and AD in a resistant 




Cohen’s kappa test was used to evaluate CA, as it accounts for the possibility of CA occurring 
by chance. The κ results is a value between 0, which represents no agreement, and 1, 
representing complete agreement 10. We also determined the systematic difference between AD 
and Etest and between Etest observations in laboratory A and laboratory B by calculating the 
mean difference in 2 fold dilution steps. 





Due to low quality of the photographs, 2/456 Etest observations were not interpreted, leaving 
454 Etests for analysis. Growth of macrocolonies within the inhibition zone was reported in 268 
of 454 (59%) Etest interpretations, (laboratory A 132/228 (58%); laboratory B 136/226 (60%)). In 
71 of 454 observations (16%) 5 or more macrocolonies were observed, meaning a switch in the 
recommended MIC from MIC80% to MIC100%.  
Agreement Etest to AD 
Overall, EA and A between the Etest MIC and AD was 57% and 89%, respectively (mean κ-
value  0.68, 95%CI 0.42:0.95, table 1). Categorical disagreement resulted in 4% VMEs and 7% 
MEs. Small differences existed between laboratories and observers. For E. coli, CA between 
Etest and AD was 100%, in contrast with the other species (range 77-91%). Reading the MIC at 
80% inhibition resulted in a higher agreement than the recommended MIC (mean κ-value 0.80, 
95%CI 0.54:1.07). We observed a significant systematic difference between mean AD and Etest 












Agreement between Etest observations 
The overall EA between all Etest observations was 911/1582 (58%) and CA was 1404/1582 
(89%) with a κ-value of 0.68 (95%CI:0.63:0.73, table 2). The IO agreement was higher than the 
IL-agreement. The MIC80% interpretation resulted in a significantly higher kappa (0.81, 95%CI 
0.76-0.86) than the recommended MIC. EA and CA between all eight observations was reached 
for 8/57 (14%) and 37/57 isolates (65%), respectively. CA was 100% for E.coli, and lower for the 
other species. EA was highest for E.cloacae (70%). The mean systematic difference between 




In this study on 57 ESBL-producing Enterobacteriaceae strains of four different species, IOIL 
agreement was low (EA 40%, CA 85%), affected most by IL agreement and to a lesser extent 
by IO agreement. No previous studies reported the IO or IL agreement for reading the 
fosfomycin Etest. A systematic difference was found with significantly higher MIC’s observed in 
laboratory A than in laboratory B. 
Factors that may have affected IL agreement were the materials used – such as the Mueller 
Hinton agar (a non-synthetic medium that may differ in composition between companies) - and 
the technician that performed the test. It confirms that there is a significant variation in MIC 
determination between labs, and MIC values obtained should be regarded with certain caution. 
11 
A significant systematic difference was found between AD and Etest leading to an 
underestimation of the Etest. The low agreement of Etest observations to AD is in line with other 
studies, as well as the higher agreement for E. coli compared to other Enterobacteriaceae.5,12,13 
In contrast to the other species, in E. coli the presence or absence of the FosA gene resulted in 
either very high or very low MICs.  
Growth of macrocolonies in the inhibition zone was observed in the majority of Etests. Ignoring 
macrocolonies and haze from interpretation (MIC80%) improved CA to AD (from 89% to 94%, 
mean κ-value 0.80) and between Etest observations (from 89% to 95%, κ-value 0.81). Our 
results suggest that the more feasible MIC80% interpretation performs better than the 












Our study has several limitations. Firstly, we used a small population of ESBL-producing 
Enterobacteriaceae isolates from hospitalized patients in the Netherlands. The majority of 
isolates appeared susceptible to fosfomycin using the current breakpoints. This could affect the 
generalizability of the results. Otherwise, we aimed to include a large enough number of 
resistant strains to allow a good estimate of VMEs, as this is can be a problem when using 
isolates with from large surveys with a low resistance frequency. Secondly, we did not interpret 
the actual Etests, but the photographs, which is not the normal practice.  
Conclusions: 
In conclusion, the fosfomycin Etest has a low IO-IL agreement and low agreement to AD. The 
observed variations in the interpretation of the fosfomycin Etest questions its general use in 
clinical practice. The better performance for E.coli isolates compared to other species supports 
the suggestion to limit its use to E.coli. 4,5 Finally, performance and feasibility might improve 
when ignoring all growth in the inhibition zone. 
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Table 1: Comparison between fosfomycin Etest and agar dilution 
      








Agar dilution 57 11 
(19) 
N/A N/A N/A N/A N/A 
Etest - recommended 
MIC  








17 (4) 31 (7) 








12 (5) 9 (4) 








5 (2) 22 (10) 








4 (4) 8 (7) 








5 (4) 5 (4) 








4 (4) 7 (6) 
Observer 4
##






97 (87) 4 (4) 11 (10) 

















99 (77) 13 (10) 16 (13) 




63 (89) 4 (6) 4 (6) 






0 (0) 11 (9) 












(18) (64) 1.07) (94) 
Etest - MIC100%
###








11 (2) 148 (33) 










22 (5) 30 (7) 
* Etest gives a  susceptible result and Agar Dilution  a resistant result. 
** Etest gives a resistant result and Agar Dilution a susceptible result.  
#
Agar Dilution measured MIC’s  up to  ≥128mh/L. For these isolates Etest MIC’s ≥64mg/L were classified as Agreement 
##
Observer 4 rated two Etests as not assessable because of low quality of the photographs; these were excluded from all analyses.  
###
Observer 4 left one MIC100 result empty. 
$
















Table 2: Overall, interobserver, interlaboratory and interlaboratory-interobserver agreement for 
the reading of fosfomycin Etest, provided by the kappa value, categorical agreement (CA,%) and 
essential agreement (EA,%)  
 








Recommended MIC 1582 911 (58) 1404 (89) 0.68 (0.63-0.73) 
 Interobserver Laboratory 
A 
342 258 (75) 321 (94) 0.79 (0.68-0.90) 
Laboratory B 336 297 (88) 315 (94) 0.84 (0.74-0.95) 
Interlaboratory Observer 1 57 19 (33) 49 (86) 0.60 (0.34-0.87) 
Observer 2 57 18 (32) 51 (89) 0.66 (0.40-0.93) 
Observer 3 57 22 (39) 48 (84) 0.54 (0.27-0.80) 
Observer 4
#
 55 26 (47) 44 (80) 0.50 (0.23-0.76) 




E.coli 448 287 (64) 448 (100) 1.00 (0.91-1.09) 
K. pneumoniae 448 186 (42) 359 (80) 0.21 (0.12-0.31) 
K. oxytoca 245 129 (53) 213 (87) 0.36 (0.24-0.49) 
E. cloacae 441 309 (70) 384 (87) 0.20 (0.10-0.29) 
MIC80% 1582 977 (62) 1495 (95) 0.81 (0.76-0.86) 
MIC100%
##
 1575 900 (57) 1240 (79) 0.58 (0.53-0.63) 
CLSI breakpoint 1582 911 (58) 1450 (92) 0.74 (0.69-0.79) 
#
 Observer 4 rated two Etests as not assessable because of low quality of the photographs; these were excluded from all analyses.  
##
Observer 4 left one MIC100 result empty. 
*
Mean kappa with mean 95% confidence interval 
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